What this means
This is a trial plan that is still recruiting people, and no results are posted yet. It does not yet tell us whether wine affects health or aging.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 35–36
- Where
- 1 site
The science
- Registered title
- Deciphering the Effect of Moderate Wine Consumption on Healthy Aging Through Postprandial Extracellular Vesicles.
- Trial ID
- NCT07361887 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Atherosclerosis Cardiovascular Disease, Obesity, Metabolic Syndrome, Metabolic Disorders, Inflammation, Neurodegeneration, Neurodegenerative Disease, Alzheimer s Disease
- What is tested
- White Wine, Red Wine, Water
- Sponsor
- University of Seville
- Ages
- 35 Years to 36 Years
- Dates
- First posted Jan 23, 2026 · updated Jan 23, 2026
Registry summary
This study aims to investigate how moderate wine consumption influences circulating extracellular vesicles (EVs) in healthy adults. EVs are small particles released by cells that carry proteins, lipids, and genetic material, and play important roles in communication between cells. Participants will consume a single serving of red or white wine, and blood samples will be collected before and after consumption to study changes in the composition and function of EVs. The study will also assess how these EVs affect vascular, immune, and brain-related cells. The results are expected to improve our understanding of how moderate wine intake contributes to cardiovascular and brain health.
Sites (1)
- Av. de Sánchez Pizjuán, s/n, 41009 Sevilla Facultad de Medicina . Universidad de Sevilla, Seville, Sevilla, Spain